Outcomes of Tranexamic Acid Treatment in Patients with Upper Gastrointestinal Bleeding: An Overview of Reviews
Keywords:
internal medicine, tranexamic acid, upper gastrointestinal bleeding, rebleeding, mortality.Abstract
Background: Upper gastrointestinal bleeding (UGIB) is a life-threatening emergency requiring prompt management. Standard treatments include endoscopic intervention, blood transfusions, and pharmacological therapies such as proton pump inhibitors (PPIs) and antifibrinolytics like tranexamic acid (TXA). However, the efficacy of TXA in UGIB remains controversial due to mixed findings. This systematic review analyzed six systematic reviews covering 34,351 patients. The objective is to assess TXA’s effectiveness in reducing mortality, rebleeding, and thromboembolic events, as well as secondary outcomes such as transfusion requirements, surgery, hospital stay, and adverse events. Methods: Studies on non-GI bleeding, pediatric populations, and non-peer-reviewed articles were excluded. A comprehensive search across PubMed, Cochrane Library, ScienceDirect, and DOAJ (2014–2024) identified 157 records, with six systematic reviews/meta-analyses (34,351 participants) meeting inclusion criteria. Risk of bias was assessed using AMSTAR 2, with two studies rated as high confidence and four as moderate confidence. Results: Current high-quality evidence does not support routine TXA use for mortality reduction in UGIB. Safety remains uncertain, particularly with prolonged high-dose administration. Conclusion: These findings are consistent with the 2022 Indonesian national consensus, which advises against routine TXA use in UGIB. Future research should focus on optimized dosing strategies, timing of administration, and identification of clinically relevant subgroups to clarify its therapeutic role.References
Kamboj AK, Hoversten P, Leggett CL. Upper gastrointestinal bleeding: Etiologies and management. Mayo Clin Proc. 2019;94(4):697–703.
Wilkins T, Wheeler B, Carpenter M. Upper Gastrointestinal bleeding in adults: Evaluation and management. Am Fam Physician. 2020;101(5):294–300.
Orpen-Palmer J, Stanley AJ. Update on the management of upper gastrointestinal bleeding. BMJ Med. 2022;1(1):e000202.
Merza N, Masoud AT. Trends of upper gastrointestinal bleeding mortality in the United States before and during the COVID-19 era: Estimates from the centers for disease control WONDER database. Gastroenterol Res. 2023;16(3):165–70.
Aljarad Z, Mobayed BB. The mortality rate among patients with acute upper GI bleeding (with/without EGD) at Aleppo University Hospital: A retrospective study. Ann Med Surg. 2021;71:102958.
Moledina SM, Komba E. Risk factors for mortality among patients admitted with upper gastrointestinal bleeding at a tertiary hospital: a prospective cohort study. BMC Gastroenterol. 2017;17(1):165.
Sayuti M, Aulia I. Epidemiology and etiology of bleeding gastrointestinal tract at Cut Meutia General Hospital, North Aceh, 2019-2021. J Med Nusant. 2023;1(3):69–74.
Bennett C, Klingenberg SL, Langholz E, et al. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2014;2014(11): CD006640.
Brenner A, Afolabi A, Ahmad SM, et al. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. Trials. 2019;20(1):467.
Burke E, Harkins P, Ahmed I. Is there a role for tranexamic acid in upper GI bleeding? A systematic review and meta-analysis. Surg Res Pract. 2021;2021:8876991.
Cai J, Ribkoff J, Olson S, et al. The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol. 2019;104(2):79.
Ker K, Mansukhani R, Shakur-Still H, et al. Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ Open. 2023;13(2):e059982.
Dionne JC, Oczkowski SJW, Hunt BJ, et al. Tranexamic acid in gastrointestinal bleeding: A systematic review and meta-analysis. Crit Care Med. 2022;50(3):E313–9.
Lee PL, Yang KS, Tsai HW, et al. Tranexamic acid for gastrointestinal bleeding: A systematic review with meta-analysis of randomized clinical trials. Am J Emerg Med. 2021;45:269–79.
Scherdin Y, Halldestam I, Redeen S. Incidence and mortality related to gastrointestinal bleeding, and the effect of tranexamic acid on gastrointestinal bleeding. Gastroenterol Res. 2021;14(3):165–72.
Indonesian Society of Gastroenterology. National consensus on management of non-variceal upper gastrointestinal tract bleeding in Indonesia. Acta Med Indones. 2022;46(2):163–71.
O’Donnell O, Gallagher C, Davey MG, et al. A systematic review and meta-analysis assessing the use of tranexamic acid (TXA) in acute gastrointestinal bleeding. Ir J Med Sci. 193(2).
Kamal F, Khan MA, Lee-Smith W, et al. Efficacy and safety of tranexamic acid in acute upper gastrointestinal bleeding: meta-analysis of randomised controlled trials. Scand J Gastroenterol. 2020;55(12):1390–7.
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:4008.
Nutbeam T. In adult patients presenting as emergencies with upper gastrointestinal bleeding, does tranexamic acid decrease mortality? African J Emerg Med. 2015;5(2):85–92.
Twum-Barimah E, Abdelgadir IS, Gordon M, et al. Tranexamic acid for upper gastrointestinal bleeding: A systematic review and meta-analysis of randomized controlled trials. Gastroenterology. 2020;158(6):S-583.
Kan SW, Tan YP, Tay MZ, et al. Tranexamic acid with acid suppression versus acid suppression alone as therapy for upper gastrointestinal bleeding: A meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2024;1–6.
Lau LHS, Sung JJY. Treatment of upper gastrointestinal bleeding in 2020: New techniques and outcomes. Dig Endosc. 2021;33(1):83–94.
Colomina MJ, Contreras L, Guilabert P, et al. Clinical use of tranexamic acid: evidence and controversies. Brazilian J Anesthesiol (English Ed. 2022;72(6):795–812.
Roberts I, Shakur-Still H, Afolabi A, et al. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10241):1927–36.
Roberts I, Prieto-merino D, Manno D. Mechanism of action of tranexamic acid in bleeding trauma patients : an exploratory analysis of data from the CRASH-2 trial. 2014;1–5.
Rațiu I, Lupușoru R, Popescu A, et al. Acute gastrointestinal bleeding: A comparison between variceal and nonvariceal gastrointestinal bleeding. Medicine (Baltimore). 2022;(October).
Franchini M, Mannucci PM. The never-ending success story of tranexamic acid in acquired bleeding. Haematologica. 2020;105(5):1201–5.
Meneses E, Boneva D, McKenney M, et al. Massive transfusion protocol in the adult trauma population. Am J Emerg Med. 2020;38(12):2661–6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Medica Indonesiana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
